These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7743513)

  • 41. The cytochrome b5 tail anchors and stabilizes subdomains of human DNA topoisomerase II alpha in the cytoplasm of retrovirally infected mammalian cells.
    Soltermann A; Ernst A; Leroy D; Stahel RA; Gasser SM
    Exp Cell Res; 1999 Jun; 249(2):308-19. PubMed ID: 10366430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    Sullivan DM; Eskildsen LA; Groom KR; Webb CD; Latham MD; Martin AW; Wellhausen SR; Kroeger PE; Rowe TC
    Mol Pharmacol; 1993 Feb; 43(2):207-16. PubMed ID: 8094226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cytotoxic effect of topoisomerase II inhibitors against adriamycin- and etoposide-resistant small cell lung cancer sublines].
    Takigawa N; Ohnoshi T; Ueoka H; Yonei T; Kiura K; Tabata M; Kodani T; Kamei H; Segawa Y; Shibayama T
    Gan To Kagaku Ryoho; 1993 May; 20(7):929-35. PubMed ID: 8387762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y; Takano H; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular analysis of a potentially phorbol-regulatable region of the human topoisomerase II alpha gene promoter.
    Loflin PT; Hochhauser D; Hickson ID; Morales F; Zwelling LA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):489-96. PubMed ID: 8166723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines.
    Kaufmann SH; Mabry M; Jasti R; Shaper JH
    Cancer Res; 1991 Jan; 51(2):581-6. PubMed ID: 1985776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The novel human HUEL (C4orf1) gene maps to chromosome 4p12-p13 and encodes a nuclear protein containing the nuclear receptor interaction motif.
    Sim DL; Chow VT
    Genomics; 1999 Jul; 59(2):224-33. PubMed ID: 10409434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
    Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
    Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples.
    Dingemans AM; Van Ark-Otte J; Smit EF; Postmus PE; Giaccone G
    Anticancer Res; 2000; 20(5B):3549-54. PubMed ID: 11131661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
    Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.
    Matsumoto Y; Takano H; Fojo T
    Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.
    Evans CD; Mirski SE; Danks MK; Cole SP
    Cancer Chemother Pharmacol; 1994; 34(3):242-8. PubMed ID: 8004758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I.
    Hasegawa T; Isobe K; Nakashima I; Shimokata K
    Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.
    Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J
    Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II.
    Bouillé P; Subra F; Goulaouic H; Carteau S; Auclair C
    Cancer Res; 1995 Jul; 55(14):3211-7. PubMed ID: 7606743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topoisomerase II alpha and beta in human tumor cells grown in vitro and in vivo.
    Prosperi E; Sala E; Negri C; Oliani C; Supino R; Astraldi Ricotti GB; Bottiroli G
    Anticancer Res; 1992; 12(6B):2093-9. PubMed ID: 1338275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.
    de Lucio B; Manuel V; Barrera-Rodríguez R
    Cancer Sci; 2005 Nov; 96(11):774-83. PubMed ID: 16271071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
    Sorensen M; Sehested M; Jensen PB
    Br J Cancer; 1995 Aug; 72(2):399-404. PubMed ID: 7640225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Bugg BY; Danks MK; Beck WT; Suttle DP
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.